The association between rheumatoid arthritis and the HLA antigen DR4.

Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis (2001) 2.39

Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis (1998) 2.09

Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis (1988) 1.66

Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed (2005) 1.19

HLA antigens and seronegative rheumatoid arthritis. Ann Rheum Dis (1985) 1.00

Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4. Rheumatol Int (1984) 0.95

Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor. Ann Rheum Dis (1990) 0.94

Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann Rheum Dis (1993) 0.82

Weak association between HLA-DR4 and rheumatoid arthritis in Chilean patients. Ann Rheum Dis (1990) 0.81

[Pathogenesis of parodontitis in rheumatic diseases]. Z Rheumatol (2010) 0.81

DR4 prevalence related to the age at disease onset in female patients with rheumatoid arthritis. Ann Rheum Dis (1989) 0.77

HLA-DR4 does not predispose to higher amounts of rheumatoid factors in healthy persons. Ann Rheum Dis (1983) 0.75

1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis (1958) 24.41

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med (1978) 7.97

Joseph J. Bunim Memorial Lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease. Arthritis Rheum (1976) 3.16

Histocompatibility antigens and rheumatoid arthritis. Arthritis Rheum (1973) 1.98

HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97

Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum (1977) 1.95

HL-A antigens in sarcoidosis and rheumatoid arthritis. Lancet (1972) 1.84

Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1969) 1.58

Prognostic value of early features in rheumatoid disease. Br Med J (1976) 1.53

HLA--Dw4 and rheumatoid arthritis. Tissue Antigens (1979) 1.36

Bottle feeding as a risk factor for cholera in infants. Lancet (1979) 1.31

HLA-DRW4 and prognosis in rheumatoid arthritis. Lancet (1978) 1.19

HL-A antigens in rheumatoid arthritis. Vox Sang (1972) 1.17

HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.06

Mixed lymphocyte reaction in healthy women with rheumatoid factor. Lack of association with HLA-Dw4. Arthritis Rheum (1979) 1.02

The human major histocompatibility complex HLA: some recent developments. Transplant Proc (1979) 0.93

Familial rheumatoid arthritis and HLA-DRw4. Lancet (1979) 0.84

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30

Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98

A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest (1974) 2.78

HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72

HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol (1978) 2.70

HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58

The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17

Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09

The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem (1974) 2.02

[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02

HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97

Severe intestinal involvement in Wegener's granulomatosis: report of two cases and review of the literature. Br J Rheumatol (1998) 1.97

Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol (1972) 1.97

Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein. Scand J Immunol (1975) 1.89

Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85

Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85

Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol (1977) 1.84

Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82

Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77

Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease. Gut (1975) 1.77

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. Ann Rheum Dis (1985) 1.74

The prevalence of fibromyalgia among women aged 20-49 years in Arendal, Norway. Scand J Rheumatol (1992) 1.70

HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67

Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66

Immunohistochemical studies of interleukin-2 and gamma-interferon in rheumatoid arthritis. Arthritis Rheum (1985) 1.62

Immunological characterization of lymphocytes in synovial fluid from patients with rheumatoid arthritis. Scand J Immunol (1973) 1.59

Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53

HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53

Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53

Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease. J Clin Invest (1975) 1.52

T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52

Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51

The human mixed lymphocyte-endothelium culture interaction. Transplantation (1975) 1.50

Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol (1985) 1.47

CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45

A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med (1992) 1.45

Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43

Amyloid-related serum protein SAA from three animal species: comparison with human SAA. J Immunol (1977) 1.43

Antigen-presenting properties of human vascular endothelial cells. J Exp Med (1980) 1.43

HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev (1982) 1.42

Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol (1973) 1.41

The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region. J Exp Med (1977) 1.38

Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38

T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35

Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol (1989) 1.35

Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol (1977) 1.33

Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33

An epidemiological survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol (1985) 1.33

In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32

Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32

Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32

Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32

On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31

Unique amyloid protein subunit common to different types of amyloid fibril. Nature (1973) 1.30

The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30

A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol (1996) 1.30

Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27

The human major histocompatibility system. Transplant Rev (1974) 1.25

New, third class of amyloid fibril protein. J Exp Med (1974) 1.25

Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24

A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens (1999) 1.22

HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes (1997) 1.22

HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens (1971) 1.22

The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J (1981) 1.22

Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22

An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis. Scand J Immunol (1980) 1.21

Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19

Cell specific and common antigens on human granulocytes and lymphocytes demonstrated with cytotoxic hetero-antibodies. Vox Sang (1967) 1.19

Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19

Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol (1983) 1.19

Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis. Scand J Gastroenterol (1973) 1.18

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17

Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology (1997) 1.17

HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17

Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol (2001) 1.17

Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera. Transplant Proc (1979) 1.17

The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum (1993) 1.16

Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16

Characterization of renal tissue lymphocytes in patients with interstitial nephritis. Am J Med (1981) 1.15

Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol (1987) 1.15

Chemical and clinical classification of amyloidosis 1985. Scand J Immunol (1986) 1.14

Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol (1985) 1.14

HLA DR antigens and gold toxicity. Ann Rheum Dis (1983) 1.14

Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink. J Exp Med (1976) 1.14

A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol (1999) 1.13

A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand J Immunol (1988) 1.13

Predominance of T cells in the lymphocytic infiltrates of synovial tissues in rheumatoid arthritis. Arthritis Rheum (1976) 1.13

Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12

The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford) (2001) 1.11

Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11

Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11

Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol (1981) 1.10

N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V. Scand J Immunol (1974) 1.10

Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. J Immunol Methods (1977) 1.10